You raise very plausible points. I hadn't thought of the recent uptick in violence as a potential factor. Perhaps they should consider either opening a second facility or moving the research facility to a safer location as a hedge against local conditions.
There also seems to be a lack of any recent analyst coverage. HC Wainwright issued a $4 price target back in September but I'm not aware of any updated forecast.
This company needs to do more outreach to analysts and generate more coverage to counteract the CC Abbott effect. Investor relations is practically non-existent. I've sent several questions to that dept. with no response. That's certainly not confidence-inspiring to say the least.